Can a probable benign breast mass on ultrasound affect a mastopexy (breast lift) procedure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: April 10, 2025 • View editorial policy

From the Guidelines

A probable benign breast mass on ultrasound should be thoroughly evaluated before proceeding with a mastopexy procedure to ensure patient safety and optimal outcomes. This recommendation is based on the American College of Radiology Appropriateness Criteria, which emphasize the importance of imaging evaluation for palpable breast masses, including diagnostic mammography and targeted-breast ultrasound 1. When a breast mass is identified, even if it is likely benign, it is crucial to consider its location, size, and characteristics in the context of mastopexy planning.

Key considerations in the management of a probable benign breast mass in the setting of mastopexy include:

  • The need for additional imaging or biopsy to confirm the benign nature of the mass
  • Potential modification of the surgical approach to avoid disrupting the mass
  • Possible removal of the mass during the mastopexy procedure for pathological evaluation
  • The importance of avoiding complications that could impact future breast imaging interpretation or mass evaluation

The American College of Radiology guidelines, as outlined in the document on appropriateness criteria for palpable breast masses 1, support a cautious approach to managing breast masses, even when they are likely benign. This approach prioritizes patient safety and ensures the best possible outcomes in terms of morbidity, mortality, and quality of life. By thoroughly evaluating and addressing the breast mass before proceeding with mastopexy, surgeons can minimize potential risks and complications, ultimately leading to better patient care.

From the Research

Probable Benign Breast Mass on Ultrasound and Mastopexy Procedure

  • A probable benign breast mass on ultrasound is typically categorized as BI-RADS 3 by the American College of Radiology Breast Imaging Reporting and Data System 2, 3.
  • Studies have shown that the negative predictive value of ultrasound for breast masses with probably benign morphology is high, ranging from 99.4% to 100% 2, 3.
  • This suggests that the likelihood of a probably benign breast mass on ultrasound being malignant is low.
  • However, there is limited research on the specific impact of a probable benign breast mass on a mastopexy procedure.
  • Mastopexy, or breast lift surgery, is a cosmetic procedure that aims to reshape and lift the breasts 4.
  • The presence of a breast mass, even if probably benign, may affect the planning and execution of a mastopexy procedure.
  • For example, the mass may need to be biopsied or removed before the mastopexy procedure can be performed 5.
  • Additionally, the mass may affect the placement of incisions or the overall aesthetic outcome of the procedure.
  • Further research is needed to fully understand the impact of a probable benign breast mass on a mastopexy procedure.
  • Contrast-enhanced ultrasound imaging may be a useful tool in evaluating breast masses and reducing the number of false-positive biopsy results 6.
  • However, its specific application in the context of mastopexy procedures is not well established.

References

Guideline

acr appropriateness criteria<sup>®</sup> palpable breast masses.

Journal of the American College of Radiology, 2017

Research

Probably Benign Solid Breast Lesions on Ultrasound: Need for Biopsy Reassessed.

Asian Pacific journal of cancer prevention : APJCP, 2018

Research

Contrast-Enhanced Ultrasound Imaging of Breast Masses: Adjunct Tool to Decrease the Number of False-Positive Biopsy Results.

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.